CLDX Celldex Therapeutics, Inc.
Healthcare$30.73+0.49%ClosedMarket Cap: $2.04B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$51.00
Target (Median)
$51.00
Target Range
$48.00 - $54.00
Upside from current price: 66.0%
Rating Distribution
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-08 | Barclays | maintain | Overweight | Overweight |
| 2026-03-02 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-02-26 | Stifel | maintain | Buy | Buy |
| 2025-12-17 | Barclays | maintain | Underweight | Underweight |
| 2025-11-11 | Barclays | maintain | Underweight | Underweight |
| 2025-09-17 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-08-20 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-08-20 | Citigroup | maintain | Buy | Buy |
| 2025-08-20 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.40 | $8.3M | 8 |
| Sun Dec 31 | $-3.21 | $147.8M | 9 |
| Mon Dec 31 | $-0.11 | $507.1M | 3 |
| Tue Dec 31 | $3.88 | $963.4M | 3 |